143 related articles for article (PubMed ID: 8006404)
1. Effect of development on the functional and histological changes induced by bile-duct ligation in the rat.
Zimmermann H; Blaser H; Zimmermann A; Reichen J
J Hepatol; 1994 Feb; 20(2):231-9. PubMed ID: 8006404
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
3. Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress.
Costa AM; Tuchweber B; Lamireau T; Yousef IM; Balabaud C; Rosenbaum J; Desmoulière A
Virchows Arch; 2003 Apr; 442(4):372-80. PubMed ID: 12715172
[TBL] [Abstract][Full Text] [Related]
4. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
5. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
[TBL] [Abstract][Full Text] [Related]
6. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
Buters JT; Zysset T; Reichen J
Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
[TBL] [Abstract][Full Text] [Related]
8. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis.
Krähenbühl S; Stucki J; Reichen J
Hepatology; 1992 Jun; 15(6):1160-6. PubMed ID: 1592354
[TBL] [Abstract][Full Text] [Related]
9. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte.
Krähenbühl S; Krähenbühl-Glauser S; Stucki J; Gehr P; Reichen J
Hepatology; 1992 Jun; 15(6):1167-72. PubMed ID: 1592355
[TBL] [Abstract][Full Text] [Related]
10. Changes in biliary excretory mechanisms in bile duct-ligated rat.
Takikawa H; Wako Y; Sano N; Yamanaka M
Dig Dis Sci; 1996 Feb; 41(2):256-62. PubMed ID: 8601367
[TBL] [Abstract][Full Text] [Related]
11. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mechanisms causing hypoalbuminemia in rats with long-term bile duct ligation.
Krähenbühl S; Marti U; Grant I; Garlick PJ; Ballmer PE
J Hepatol; 1995 Jul; 23(1):79-86. PubMed ID: 8530813
[TBL] [Abstract][Full Text] [Related]
13. Biliary retention in a chronic choledocho-venous fistula in the rat: induction of portal hypertension but not of biliary cirrhosis.
Zimmermann H; Reichen J; Sägesser H; Tenisch B; Zimmermann A
J Hepatol; 1993 Aug; 19(1):110-6. PubMed ID: 8301031
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of resveratrol against oxidative stress in cholestasis.
Ara C; Kirimlioglu H; Karabulut AB; Coban S; Ay S; Harputluoglu M; Kirimlioglu V; Yilmaz S
J Surg Res; 2005 Aug; 127(2):112-7. PubMed ID: 16083749
[TBL] [Abstract][Full Text] [Related]
15. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism.
Peterson TC; Neumeister M
Immunopharmacology; 1996 Mar; 31(2-3):183-93. PubMed ID: 8861744
[TBL] [Abstract][Full Text] [Related]
16. Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
Liver; 1996 Feb; 16(1):12-8. PubMed ID: 8868072
[TBL] [Abstract][Full Text] [Related]
17. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
18. Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.
Dondorf F; Fahrner R; Ardelt M; Patsenker E; Stickel F; Dahmen U; Settmacher U; Rauchfuß F
World J Gastroenterol; 2017 Jun; 23(23):4191-4199. PubMed ID: 28694659
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
20. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat.
Zimmermann H; Reichen J; Zimmermann A; Sägesser H; Thenisch B; Höflin F
Gastroenterology; 1992 Aug; 103(2):579-89. PubMed ID: 1634077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
